Skip to main content
SpringerLink
Log in

Introduction to Tyrosine Kinase Inhibitors: Pazopanib Cardiotoxicity

  • Chapter
  • First Online:
Atlas of Imaging in Cardio-Oncology

  • 682 Accesses

Abstract

The understanding of the role of dysregulated tyrosine kinases in cancer has produced a literal explosion in approaches to cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Reference

  1. Paul MK, Mukhopadhyay AK. Tyrosine kinase—role and significance in cancer. Int J Med Sci. 2004;1(2):101–115. https://doi.org/10.7150/ijms.1.101. PMID: 15912202; PMCID: PMC1074718.

  2. Cheng H, Force T. Why do kinase inhibitors cause cardiotoxicity and what can be done about it? Prog Cardiovasc Dis. 2010;53(2):114–20. https://doi.org/10.1016/j.pcad.2010.06.006. PMID: 20728698.

  3. Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1. J Am Coll Cardiol. 2017;70(20):2536–51. https://doi.org/10.1016/j.jacc.2017.09.1096.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. Cancer J Clin. 2020;70(1):7. PMID: 31912902.

    Google Scholar 

  5. Casali P.G., Abecasis N, Bauer S., et al. Soft tissue and visceral sarcomas: ESM-EURACA clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(4):iv51–iv67. https://doi.org/10.1093/annonc/mdy096.

  6. Krieg AH, Hefti F, Speth BM, et al. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol. 2011;22(458). PMID: 20716627.

    Google Scholar 

  7. Rothermundt C, Whelan JS, Dileo P, et al. What is the role of routine follow-up for localized limb soft tissue sarcomas? A retrospective analysis of 174 patients. Br J Cancer. 2014;110(2420). PMID: 24736584.

    Google Scholar 

  8. Votrient [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2017. https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/votrient.pdf. Accessed 19 Aug 2017.

  9. Pinkhas D., Ho T., Smith S. Assessment of pazopanib-related hypertension, cardiac dysfunction and identification of clinical risk factors for their development. Cardiooncology. 2017;3(5). MCID: PMC5828231. https://doi.org/10.1186/s40959-017-0024-8.

Download references

Author information

Authors and Affiliations

  1. Cardiology Center, Federal Scientific and Research Center, FMBA Russia, Orekhovy Bulvar, 28, 115285, Moscow, Russia

    David P. Dundua & Ekaterina V. Plokhova

  2. Department of Oncology, Federal Scientific and Research Center, FMBA Russia, Orekhovy Bulvar, 28, 115285, Moscow, Russia

    Ana G. Kedrova

  3. Department of Radiology, Federal Scientific and Research Center, FMBA Russia, Orekhovy Bulvar, 28, 115285, Moscow, Russia

    Elena A. Zvezdkina & Olga A. Drobiazko

Authors
  1. David P. Dundua
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana G. Kedrova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ekaterina V. Plokhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elena A. Zvezdkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olga A. Drobiazko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David P. Dundua .

Editor information

Editors and Affiliations

  1. Department of Medicine, Cardiology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Richard M. Steingart

  2. Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Jennifer E. Liu

5.1 Electronic supplementary material

Below is the link to the electronic supplementary material.

Video 5.1

Echocardiogram parasternal long axis view demonstrating fluctuating mass in the right atrium (mediastinal tumor ingrowth) and mild diffuse hypokinesis of the left ventricle (PPTX 1708 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dundua, D.P., Kedrova, A.G., Plokhova, E.V., Zvezdkina, E.A., Drobiazko, O.A. (2021). Introduction to Tyrosine Kinase Inhibitors: Pazopanib Cardiotoxicity. In: Steingart, R.M., Liu, J.E. (eds) Atlas of Imaging in Cardio-Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-70998-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-70998-3_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-70997-6

  • Online ISBN: 978-3-030-70998-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation